Do you want to read an article? Please log in or register.
Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm
Ocular Oncology
Related content
Ocular Oncology
Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy
BMC Ophthalmol
Fang R, Wang H, Li Y, Liu YM, Wei WB
doi: 10.1186/s12886-021-01898-3
Ocular Oncology
Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients With Small Choroidal Melanoma Managed by Plaque Radiotherapy
JAMA Ophthalmol.
Shields CL, Sioufi K, Srinivasan A, DiNicola M, Masoomian B, Barna LE, Bekerman VP, Say EAT, Mashayekhi A, Emrich J, Komarnicky L, Shields JA
doi: 10.1001/jamaophthalmol.
Macular DiseasesOcular OncologyRetinal Diseases
Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients
Br J Ophthalmol.
Dalvin LA, Zhang Q, Hamershock RA, Chang M, Yu MD, Mashayekhi A, Shields CL
doi: 10.1136/bjophthalmol-2019-314686.
Ocular Oncology
THE SMALL FATAL CHOROIDAL MELANOMA STUDY A Survey by the European Ophthalmic Oncology Group
Am J Ophthalmol.
Jouhi S, Jager MJ, de Geus SJR, Desjardins L, Eide NA, Grange JD, Kiilgaard JF, Seregard S, Midena E, Parrozzani R, Caujolle JP, Rospond-Kubiak I, Kivelä TT
doi: 10.1016/j.ajo.2019.01.031.
Ocular Oncology
Impact of uveal melanoma thickness on post-plaque radiotherapy outcomes in the prophylactic anti-vascular endothelial growth factor era in 1131 patients
Clin Exp Ophthalmol.
Yang X, Dalvin LA, Mazloumi M, Chang M, Shields JA, Mashayekhi A, Shields CL
doi: 10.1111/ceo.13758.
COMMENTED
Ocular Oncology
Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals
★ 3
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
doi: 10.1001/jamaophthalmol.2019.5132.
Macular DiseasesRetinal Diseases
Association of choroidal thickness with intermediate age-related macular degeneration in a Japanese population
Ophthalmol Retina.
Sasaki M, Ito Y, Yamazaki T, Yanagi Y, Gemmy Cheung CM, Motomura K, Kawakami S, Kinoshita T, Yuki K, Hanyuda A, Mimura M, Sawada N, Tsugane S, Tsubota K
doi: 10.1016/j.oret.2020.09.001.
Further Publications
Five-Year Change in Choroidal Thickness in Relation to Body Development and Axial Eye Elongation: The CCC2000 Eye Study
Invest Ophthalmol Vis Sci.
Hansen MH, Li XQ, Larsen M, Olsen EM, Skovgaard AM, Kessel L, Munch IC
doi: 10.1167/iovs.19-26807.
Ocular Oncology
Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis
Br J Ophthalmol.
Thornton S, Coupland SE, Heimann H, Hussain R, Groenewald C, Kacperek A, Damato B, Taktak A, Eleuteri A, Kalirai H
doi: 10.1136/bjophthalmol-2019-315363.